Intellia Therapeutics, Inc. is a company in the U.S. stock market and it is a holding in 41 U.S.-traded ETFs. NTLA has around 10.5M shares in the U.S. ETF market. The largest ETF holder of NTLA is the ARK Innovation ETF (ARKK), with approximately 4.79M shares. Investors may also find of interest that the ETF with the largest allocation to NTLA stock is ARK Genomic Revolution ETF (ARKG), with a portfolio weight of 7.14%. On average, U.S. ETFs allocate 0.40% of NTLA to their portfolios.
Additionally, NTLA is a favorite stock for Vanilla and Exchange-specific ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with NTLA as a holding is the ARK Genomic Revolution ETF (ARKG), with a return of 10.83%.